Source: Health Canada shortage reports · Updated Oct 1, 2026
A shortage of Bleomycin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A chemotherapy medication used to treat several types of cancer.
Products affected
0 / 2
Reports on file
9
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Oct 10, 2025 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Apr 9, 2024 · Disruption of the manufacture of the drug.
Avoided
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Oct 17, 2022 · Demand increase for the drug.
Resolved
BLEOMYCIN FOR INJECTION
15UNIT · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02265982 · ended Apr 1, 2022 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Nov 16, 2020 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION
15UNIT · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02265982 · ended Nov 9, 2020 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Mar 20, 2020 · Disruption of the manufacture of the drug.
Resolved
BLEOMYCIN FOR INJECTION USP
15UNIT · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02131692 · ended Nov 18, 2019 · Demand increase for the drug.
What's happening
A manufacturer has told Health Canada it expects supply of Bleomycin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Bleomycin is classified under “CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES” (ATC L01DC).
Recent changes
Oct 1, 2026
New report filed
Common questions
What is Bleomycin used for?
A chemotherapy medication used to treat several types of cancer.
When will Bleomycin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Bleomycin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.